Cargando…

Machine Learning–Based Prediction of Growth in Confirmed COVID-19 Infection Cases in 114 Countries Using Metrics of Nonpharmaceutical Interventions and Cultural Dimensions: Model Development and Validation

BACKGROUND: National governments worldwide have implemented nonpharmaceutical interventions to control the COVID-19 pandemic and mitigate its effects. OBJECTIVE: The aim of this study was to investigate the prediction of future daily national confirmed COVID-19 infection growth—the percentage change...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeung, Arnold YS, Roewer-Despres, Francois, Rosella, Laura, Rudzicz, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074952/
https://www.ncbi.nlm.nih.gov/pubmed/33844636
http://dx.doi.org/10.2196/26628
_version_ 1783684455274119168
author Yeung, Arnold YS
Roewer-Despres, Francois
Rosella, Laura
Rudzicz, Frank
author_facet Yeung, Arnold YS
Roewer-Despres, Francois
Rosella, Laura
Rudzicz, Frank
author_sort Yeung, Arnold YS
collection PubMed
description BACKGROUND: National governments worldwide have implemented nonpharmaceutical interventions to control the COVID-19 pandemic and mitigate its effects. OBJECTIVE: The aim of this study was to investigate the prediction of future daily national confirmed COVID-19 infection growth—the percentage change in total cumulative cases—across 14 days for 114 countries using nonpharmaceutical intervention metrics and cultural dimension metrics, which are indicative of specific national sociocultural norms. METHODS: We combined the Oxford COVID-19 Government Response Tracker data set, Hofstede cultural dimensions, and daily reported COVID-19 infection case numbers to train and evaluate five non–time series machine learning models in predicting confirmed infection growth. We used three validation methods—in-distribution, out-of-distribution, and country-based cross-validation—for the evaluation, each of which was applicable to a different use case of the models. RESULTS: Our results demonstrate high R(2) values between the labels and predictions for the in-distribution method (0.959) and moderate R(2) values for the out-of-distribution and country-based cross-validation methods (0.513 and 0.574, respectively) using random forest and adaptive boosting (AdaBoost) regression. Although these models may be used to predict confirmed infection growth, the differing accuracies obtained from the three tasks suggest a strong influence of the use case. CONCLUSIONS: This work provides new considerations in using machine learning techniques with nonpharmaceutical interventions and cultural dimensions as metrics to predict the national growth of confirmed COVID-19 infections.
format Online
Article
Text
id pubmed-8074952
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-80749522021-05-06 Machine Learning–Based Prediction of Growth in Confirmed COVID-19 Infection Cases in 114 Countries Using Metrics of Nonpharmaceutical Interventions and Cultural Dimensions: Model Development and Validation Yeung, Arnold YS Roewer-Despres, Francois Rosella, Laura Rudzicz, Frank J Med Internet Res Original Paper BACKGROUND: National governments worldwide have implemented nonpharmaceutical interventions to control the COVID-19 pandemic and mitigate its effects. OBJECTIVE: The aim of this study was to investigate the prediction of future daily national confirmed COVID-19 infection growth—the percentage change in total cumulative cases—across 14 days for 114 countries using nonpharmaceutical intervention metrics and cultural dimension metrics, which are indicative of specific national sociocultural norms. METHODS: We combined the Oxford COVID-19 Government Response Tracker data set, Hofstede cultural dimensions, and daily reported COVID-19 infection case numbers to train and evaluate five non–time series machine learning models in predicting confirmed infection growth. We used three validation methods—in-distribution, out-of-distribution, and country-based cross-validation—for the evaluation, each of which was applicable to a different use case of the models. RESULTS: Our results demonstrate high R(2) values between the labels and predictions for the in-distribution method (0.959) and moderate R(2) values for the out-of-distribution and country-based cross-validation methods (0.513 and 0.574, respectively) using random forest and adaptive boosting (AdaBoost) regression. Although these models may be used to predict confirmed infection growth, the differing accuracies obtained from the three tasks suggest a strong influence of the use case. CONCLUSIONS: This work provides new considerations in using machine learning techniques with nonpharmaceutical interventions and cultural dimensions as metrics to predict the national growth of confirmed COVID-19 infections. JMIR Publications 2021-04-23 /pmc/articles/PMC8074952/ /pubmed/33844636 http://dx.doi.org/10.2196/26628 Text en ©Arnold YS Yeung, Francois Roewer-Despres, Laura Rosella, Frank Rudzicz. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 23.04.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Yeung, Arnold YS
Roewer-Despres, Francois
Rosella, Laura
Rudzicz, Frank
Machine Learning–Based Prediction of Growth in Confirmed COVID-19 Infection Cases in 114 Countries Using Metrics of Nonpharmaceutical Interventions and Cultural Dimensions: Model Development and Validation
title Machine Learning–Based Prediction of Growth in Confirmed COVID-19 Infection Cases in 114 Countries Using Metrics of Nonpharmaceutical Interventions and Cultural Dimensions: Model Development and Validation
title_full Machine Learning–Based Prediction of Growth in Confirmed COVID-19 Infection Cases in 114 Countries Using Metrics of Nonpharmaceutical Interventions and Cultural Dimensions: Model Development and Validation
title_fullStr Machine Learning–Based Prediction of Growth in Confirmed COVID-19 Infection Cases in 114 Countries Using Metrics of Nonpharmaceutical Interventions and Cultural Dimensions: Model Development and Validation
title_full_unstemmed Machine Learning–Based Prediction of Growth in Confirmed COVID-19 Infection Cases in 114 Countries Using Metrics of Nonpharmaceutical Interventions and Cultural Dimensions: Model Development and Validation
title_short Machine Learning–Based Prediction of Growth in Confirmed COVID-19 Infection Cases in 114 Countries Using Metrics of Nonpharmaceutical Interventions and Cultural Dimensions: Model Development and Validation
title_sort machine learning–based prediction of growth in confirmed covid-19 infection cases in 114 countries using metrics of nonpharmaceutical interventions and cultural dimensions: model development and validation
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074952/
https://www.ncbi.nlm.nih.gov/pubmed/33844636
http://dx.doi.org/10.2196/26628
work_keys_str_mv AT yeungarnoldys machinelearningbasedpredictionofgrowthinconfirmedcovid19infectioncasesin114countriesusingmetricsofnonpharmaceuticalinterventionsandculturaldimensionsmodeldevelopmentandvalidation
AT roewerdespresfrancois machinelearningbasedpredictionofgrowthinconfirmedcovid19infectioncasesin114countriesusingmetricsofnonpharmaceuticalinterventionsandculturaldimensionsmodeldevelopmentandvalidation
AT rosellalaura machinelearningbasedpredictionofgrowthinconfirmedcovid19infectioncasesin114countriesusingmetricsofnonpharmaceuticalinterventionsandculturaldimensionsmodeldevelopmentandvalidation
AT rudziczfrank machinelearningbasedpredictionofgrowthinconfirmedcovid19infectioncasesin114countriesusingmetricsofnonpharmaceuticalinterventionsandculturaldimensionsmodeldevelopmentandvalidation